OpenAI researcher Miles Wang plans drug-discovery AI startup, TechCrunch reports

The new venture is reportedly discussing about $200 million in funding at a roughly $2 billion valuation, with Lightspeed potentially leading the round.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.